Cargando…
Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence
A consolidated overview of evidence for the effectiveness and safety/tolerability of hepatic encephalopathy (HE) treatment over the long term is currently lacking. We identified and assessed published evidence for the long-term (≥6 months) pharmacological management of HE with lactulose and/or rifax...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams And Wilkins
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416096/ https://www.ncbi.nlm.nih.gov/pubmed/30444745 http://dx.doi.org/10.1097/MEG.0000000000001311 |